Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.16527
Abstract: Key Points Question What are the treatment outcomes and adverse events among pregnant patients with multidrug-resistant tuberculosis (MDR-TB)? Findings In a systematic review and meta-analysis of 10 studies including 275 pregnant patients with MDR-TB, the… read more here.
Keywords: pregnant patients; among pregnant; treatment outcomes; patients multidrug ... See more keywords
The Correlations of Minimal Inhibitory Concentration Values of Anti-TB Drugs with Treatment Outcomes and Clinical Profiles in Patients with Multidrug-Resistant Tuberculosis (MDR-TB) in China
Sign Up to like & getrecommendations! Published in 2022 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s374687
Abstract: Objective It is a challenge to obtain satisfactory treatment outcomes for patients with multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB); the study aims to correlate the Minimum Inhibitory Concentration (MIC) value of drugs with the outcome of patients with… read more here.
Keywords: mdr; treatment outcomes; resistant tuberculosis; patients multidrug ... See more keywords
Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Korean Medical Science"
DOI: 10.3346/jkms.2023.38.e33
Abstract: Background The treatment outcomes of patients with multidrug/rifampin-resistant (MDR/RR) tuberculosis (TB) are important indicators that reflect the current status of TB management and identify the key challenges encountered by TB control programs in a country.… read more here.
Keywords: outcomes patients; multidrug rifampin; treatment outcomes; patients multidrug ... See more keywords
The Impact of IgG administration on the cellular immunity status in the patients with multidrug-resistant tuberculosis/HIV with CD4 + lymphocyte cells below 50 cells/ μl
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Mycobacteriology"
DOI: 10.4103/ijmy.ijmy_21_21
Abstract: Background: Treatment of the patients with multidrug-resistant tuberculosis (MDR-TB)/HIV coinfection in a state of severely suppressed immune system remains unsatisfactory. Methods: The study involved 52 HIV-positive patients with MDR-TB and CD4+ lymphocyte cells below 50… read more here.
Keywords: group; multidrug resistant; patients multidrug; cd4 ... See more keywords
The impact of pyrazinamide resistance upon the treatment outcome of patients with multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
Sign Up to like & getrecommendations! Published in 2017 at "F1000Research"
DOI: 10.7490/f1000research.1114041.1
Abstract: Kuhlin, Johanna; Smith, Christopher; Khaemraev, Atadjan; Tigay, Zinaida; Parpieva, Nargiza; Tillyashaykhov, Mirzagaleb; Achar, Jay; Hajek, Jan; Greig, Jane; du Cros, Philipp; +1 more... Moore, David; (2017) The impact of pyrazinamide resistance on the treatment outcome… read more here.
Keywords: impact pyrazinamide; outcome patients; multidrug resistant; pyrazinamide resistance ... See more keywords